Posterior reversible encephalopathy syndrome (PRES) is a combined clinical and radiological syndrome characterised by headaches, encephalopathy, seizures and visual loss. We present the case of a 55-year-old male who developed this condition following treatment with deoxycoformycin and alemtuzumab. We review the literature considering diagnosis, pathophysiology and optimal strategies for treatment of this condition.
HincheyJChavesCAppignaniB A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494–500. doi:10.1056/NEJM199602223340803
3.
GargRK.Posterior leukoencephalopathy syndrome. Postgrad Med J 2001; 77:24. doi:10.1136/pmj.77.903.24
4.
DonmezFYBasaranCKayahan UluEM MRI features of posterior reversible encephalopathy syndrome in 33 patients. J Neuroimaging 2010; 20:22–28. doi:10.1111/j.1552-6569.2008.00306.x
5.
NiJZhouLXHaoH The clinical and radiological spectrum of posterior reversible encephalopathy syndrome: a retrospective series of 24 patients. J Neuroimaging 2010 Jun 21; epub ahead of print.
6.
FugateJEClaassenDOCloftHJ Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 2010; 85: 427–32. doi:10.4065/mcp.2009.0590
7.
KwonEJKimSWKimKK A case of gemcitabine and cisplatin associated posterior reversible encephalopathy syndrome. Cancer Res Treat 2009; 41:53–55. doi:10.4143/crt.2009.41.1.53
RangiPSPartridgeWJNewlandsES Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anesthesia. Neuroradiology 2005; 47: 586–90. doi:10.1007/s00234-005-1376-6
